Moderna goes on the patent offensive; Pablo Legorreta doubles down; Is a biotech recovery on the way?; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign...

Click to view original post